Industry veterans Laura Bottino, Kristin Relyea and Tracy Huckabee to lead finance, product and content teams

BOSTON—CareAcademy, the care enablement platform, announced the appointment of three executives to its leadership team. To support the company's growth strategy, Laura Bottino will serve as chief financial officer, Kristin Relyea will take on the role of vice president of product, design and engineering, and Tracy Huckabee is joining as vice president of content and quality.

The extension also grants health plans the ability to restrict MAOs from using out-of-network providers.

Hospice patients will be able to receive concurrent care with Medicare Advantage as the Centers for Medicare and Medicaid Services (CMS) extended its Value-Based Insurance Design for calendar years 2025 through 2030. The extension also grants health plans the ability to restrict Medicare Advantage Organizations (MAOs) from using out-of-network providers in 2026.

The expansion is in support of Made in USA Strategic Initiative

GF Health Products, Inc. (Graham-Field) announced an expansion of its offering of Sub-Acute Care and Extended Care Beds. Manufactured in the United States at the Basic American Bed facility in Fond-du-Lac, Wisconsin, the new beds take advantage of Graham-Field’s manufacturing resources to include computer-controlled laser welding, robotic assembly and an upgraded automated coating line.

Opportunity to accelerate long-term organic growth and expand patient access

CINCINNATI—Quipt Home Medical Corp. (“Quipt” or the “Company”) a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, announced the execution of a national insurance contract with a top five health insurer based on membership in the United States. This represents the second national insurance contract Quipt has signed since April 2022.

Through the collaboration, WorldView and Care Coordinations simplify communication between providers about their patients

OMAHA, Nebraska—Enterprise content management solution WorldView announced a new partnership with Care Coordinations, designed to help home health and hospice agencies simplify, organize and automate real-time communication and care coordination between providers, caregivers and patients in care-at-home settings.

Capone will speak on “Virtual First Approach to Augment Consumer Care Delivery at Home.”

NEW YORK—DocGo a provider of last-mile mobile health services, announced Anthony Capone, CEO, will participate in a panel at HIMSS23 in Chicago, speaking on the topic of a “Virtual First Approach to Augment Consumer Care Delivery at Home.” This panel, led by Kent Dicks, founder and CEO of Life365, will explore the latest opportunities and challenges to effectively implement a virtual first approach to delivering home health care and the outlook for its demand and adoption.

Medtrade 2023 took place in Dallas for the first time since it was announced it would be held once, instead of twice a year.

DALLAS, Texas—The first “annual” Medtrade took place in Dallas from March 28 to 30. Before the Dallas edition of the show, the largest home medical equipment trade show in the U.S. was held twice a year at “East” and “West” shows. However, in 2023, the conference officially merged, becoming one large central show that will be held once a year.

Birmingham, ALABAMA—A new report released last month by the National Association for Home Care & Hospice (NAHC) and the National Hospice and Palliative Care Organization (NHPCO) found that Medicare spending for patients who received hospice care was some $3.5 billion less than it would if they had not gotten that care. HomeCare talked with NAHC President Bill Dombi about the report and why getting Americans on board with hospice is so important. 

Masimo Opioid Halo, an opioid overdose prevention and alert system, will be made available over the counter.

IRVINE, California—Masimo announced that Masimo Opioid Halo, an opioid overdose prevention and alert system, has been granted a De Novo by the FDA, making it the first and only FDA-cleared monitoring solution for detecting opioid-induced respiratory depression, the leading cause of death from opioid overdose. With the De Novo, Masimo also becomes the first winner of an FDA Opioid Innovation Challenge to have an authorized solution designed to help solve the U.S. opioid crisis.